CXCL10 and asthma: Ephedra has been widely used to treat asthma in Asia; a strategy of network pharmacology combined with molecular docking and in vitro experiments was performed to predict the anti-inflammatory targets of ephedra in treating asthma; the results showed that SELE, IL-2, and CXCL10 are critical targets for ephedra against inflammation due to asthma [16].